154 related articles for article (PubMed ID: 35661431)
21. FDG-PET/CT at the end of immuno-chemotherapy in follicular lymphoma: the prognostic role of the ratio between target lesion and liver SUV
Annunziata S; Cuccaro A; Tisi MC; Hohaus S; Rufini V
Ann Nucl Med; 2018 Jun; 32(5):372-377. PubMed ID: 29464479
[TBL] [Abstract][Full Text] [Related]
22. 18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading.
Wöhrer S; Jaeger U; Kletter K; Becherer A; Hauswirth A; Turetschek K; Raderer M; Hoffmann M
Ann Oncol; 2006 May; 17(5):780-4. PubMed ID: 16497824
[TBL] [Abstract][Full Text] [Related]
23. FDG-PET/CT discriminates between patients with and without lymphomas in primary Sjögren's syndrome.
van Ginkel MS; Arends S; van der Vegt B; Nijland M; Spijkervet FKL; Vissink A; Kroese FGM; Glaudemans AWJM; Bootsma H
Rheumatology (Oxford); 2023 Oct; 62(10):3323-3331. PubMed ID: 36759907
[TBL] [Abstract][Full Text] [Related]
24. Role of fluorine-18 fluoro-deoxyglucose positron emission tomography scan in the evaluation and follow-up of patients with low-grade lymphomas.
Karam M; Novak L; Cyriac J; Ali A; Nazeer T; Nugent F
Cancer; 2006 Jul; 107(1):175-83. PubMed ID: 16721817
[TBL] [Abstract][Full Text] [Related]
25. Utility of quantitative FDG-PET/CT for the detection of bone marrow involvement in follicular lymphoma: a histopathological correlation study.
Adams HJ; Kwee TC; Fijnheer R; Dubois SV; Blase PE; Nievelstein RA; de Klerk JM
Skeletal Radiol; 2014 Sep; 43(9):1231-6. PubMed ID: 24902511
[TBL] [Abstract][Full Text] [Related]
26. Aggressive cutaneous follicular lymphoma in a
Martínez-Esteve A; Moreno-Caballero M; Jiménez-Granero P; Cobo-Rodríguez A; Infante-de-la-Torre JR; Serrano-Vicente J; Rayo-Madrid JI; Martín-Marcuartu JJ
Med Clin (Barc); 2020 Jul; 155(2):91. PubMed ID: 31623822
[No Abstract] [Full Text] [Related]
27. PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study.
Tychyj-Pinel C; Ricard F; Fulham M; Fournier M; Meignan M; Lamy T; Vera P; Salles G; Trotman J
Eur J Nucl Med Mol Imaging; 2014 Mar; 41(3):408-15. PubMed ID: 24435770
[TBL] [Abstract][Full Text] [Related]
28. Multiple metabolic parameters and visual assessment of
Ren Y; Liu J; Wang L; Luo Y; Ding X; Shi A; Liu J
Abdom Radiol (NY); 2020 Nov; 45(11):3569-3580. PubMed ID: 32274551
[TBL] [Abstract][Full Text] [Related]
29. Combined positron emission tomography/computed tomography for diagnosis and monitoring of orbital adnexal lymphoma.
Klingenstein A; Garip-Kuebler A; Mueller-Lisse UG; Hintschich C
Acta Ophthalmol; 2018 Sep; 96(6):e712-e717. PubMed ID: 30146694
[TBL] [Abstract][Full Text] [Related]
30. Correlations between maximum standardized uptake value measured via
Li H; Wang X; Zhang L; Yi X; Qiao Y; Jin Q
J Cancer Res Ther; 2019; 15(7):1581-1588. PubMed ID: 31939441
[TBL] [Abstract][Full Text] [Related]
31. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
[TBL] [Abstract][Full Text] [Related]
32. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility.
Basu S; Li G; Bural G; Alavi A
Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692
[TBL] [Abstract][Full Text] [Related]
33. Value of
Alobthani G; Romanov V; Isohashi K; Matsunaga K; Watabe T; Kato H; Tatsumi M; Shimosegawa E; Hatazawa J
Hell J Nucl Med; 2018; 21(1):7-14. PubMed ID: 29550841
[TBL] [Abstract][Full Text] [Related]
34. (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
Ujjani CS; Hill EM; Wang H; Nassif S; Esposito G; Ozdemirli M; Cordova C; Cheson BD
Br J Haematol; 2016 Aug; 174(3):410-6. PubMed ID: 27098364
[TBL] [Abstract][Full Text] [Related]
35. 18F-fluorodeoxyglucose positron emission tomography (18F-FDG-PET) does not visualize follicular lymphoma of the duodenum.
Hoffmann M; Chott A; Püspök A; Jäger U; Kletter K; Raderer M
Ann Hematol; 2004 May; 83(5):276-8. PubMed ID: 15060746
[TBL] [Abstract][Full Text] [Related]
36. The Value of PET/CT in Detecting Bone Marrow Involvement in Patients With Follicular Lymphoma.
Perry C; Lerman H; Joffe E; Sarid N; Amit O; Avivi I; Kesler M; Ben-Ezra J; Even-Sapir E; Herishanu Y
Medicine (Baltimore); 2016 Mar; 95(9):e2910. PubMed ID: 26945387
[TBL] [Abstract][Full Text] [Related]
37. Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine: a multicenter study.
Tateishi U; Tatsumi M; Terauchi T; Ishizawa K; Ogura M; Tobinai K
Cancer Sci; 2011 Feb; 102(2):414-8. PubMed ID: 21156007
[TBL] [Abstract][Full Text] [Related]
38. The clinical consequences of functional adrenal uptake in the absence of cross-sectional mass on FDG-PET/CT in oncology patients.
Hsiao R; Chow A; Kluijfhout WP; Bongers PJ; Verzijl R; Metser U; Veit-Haibach P; Pasternak JD
Langenbecks Arch Surg; 2022 Jun; 407(4):1677-1684. PubMed ID: 34993609
[TBL] [Abstract][Full Text] [Related]
39. (18)F-fluorodeoxyglucose positron emission tomography/computed tomography comparison of gastric lymphoma and gastric carcinoma.
Li XF; Fu Q; Dong YW; Liu JJ; Song XY; Dai D; Zuo C; Xu WG
World J Gastroenterol; 2016 Sep; 22(34):7787-96. PubMed ID: 27678362
[TBL] [Abstract][Full Text] [Related]
40. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
